Results of 2022 Annual General Meeting
In accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001, Imagion Biosystems Limited advises the results of its Annual…
Magnetic Nanoparticles as Imaging Agents Presentation at the 2021 VBIC Meeting
As a sponsor of the 2021 Annual VBIC Network Meeting, Imagion Biosystems' President and CEO, Bob Proulx, gave a presentation on magnetic nanoparticles as…
Imagion to present at Switzer Small and Microcap Investor Day
Come along to Switzer Small & Micro Cap Investor Day Switzer Financial Group is pleased to bring you the Switzer Small & Micro Cap Investor Day on…
